Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
Saved in:
| Published in: | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
- Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment
- A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment
- Vascular cognitive impairment and dementia drug‐development pipeline 2025
- When context matters: social disparities in preventable hospitalizations among Medicare beneficiaries with dementia
- Virtual reality-based cognitive assessment tools for mild cognitive impairment screening: comparison with traditional paper-and-pencil-based cognitive assessment tools
- Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment